cGAS-IN-1 is a cyclic GMP-AMP synthase (cGAS) inhibitor with potential anti-inflammatory activity; it inhibits human cGAS with an IC50 of 2.28 μM and mouse cGAS with an IC50 of 1.44 μM; it is relevant for the treatment of immune-mediated inflammatory diseases associated with aberrant cGAS activation.